Trends in lithium prescription in Spain from 1985 to 2003

Xavier Castells; Antoni Vallano; David Rigau; Joselin Pérez; Miguel Casas; Dolors Capellà

doi:10.1016/j.jad.2006.01.005

Trends in lithium prescription in Spain from 1985 to 2003

J Affect Disord. 2006 Apr;91(2-3):273-6. doi: 10.1016/j.jad.2006.01.005. Epub 2006 Feb 17.

Authors

Xavier Castells¹, Antoni Vallano, David Rigau, Joselin Pérez, Miguel Casas, Dolors Capellà

Affiliation

¹ Fundació Institut Català de Farmacologia, Clinical Pharmacology Service, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Spain. [email protected]

PMID: 16483670
DOI: 10.1016/j.jad.2006.01.005

Abstract

Lithium use for bipolar disorder has decreased in the United States. We aimed at studying lithium prescription in Spain from 1985 to 2003. Prescription data, expressed in daily defined dose per 1,000 inhabitants per day, were obtained. Lithium prescription increased uninterruptedly from 0.21 to 0.79 DID. The psychiatric reform in Spain and a broader definition of BD during the last decades are possible explanations for this rise.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Bipolar Disorder / drug therapy*
Drug Prescriptions / statistics & numerical data*
Drug Therapy / trends*
Drug Utilization / statistics & numerical data*
Humans
Lithium Carbonate / therapeutic use*
Prevalence
Spain

Substances

Lithium Carbonate